SCHEMBL7653982

SCHEMBL7653982

COS(=O)(=O)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 4/20 0.42
CYP2D6 P10635 3/20 0.41
CYP19A1 P11511 1/20 0.41
GPX4 P36969 4/20 0.41
CHRM2 P08172 2/20 0.41
HTR1A P08908 2/20 0.41
ADRA2A P08913 2/20 0.41
CHRM1 P11229 2/20 0.41
DRD1 P21728 2/20 0.41
TBXA2R P21731 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
ADRA1A P35348 2/20 0.41
DRD3 P35462 2/20 0.41
SLC6A3 Q01959 2/20 0.41
KCNH2 Q12809 2/20 0.41
BCL2 P10415 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL977897 0.76 CYP3A4 (0.42) SLC6A9CYP2D6CYP19A1GPX4CHRM2
SCHEMBL3297472 0.75 CYP3A4 (0.47) SLC6A9CYP2D6CHRM2HTR1AADRA2A
SCHEMBL1780961 0.73 CYP2D6 (0.52) SLC6A9CYP2D6CYP19A1GPX4CHRM2
SCHEMBL3296307 0.72 CYP19A1 (0.42) SLC6A9CYP19A1GPX4KCNH2TSHR
SCHEMBL2913392 0.70 CRHBP (0.47) HTR1AALDH1A1
SCHEMBL1780960 0.70 CYP2D6 (0.52) SLC6A9CYP2D6CYP19A1GPX4CHRM2
SCHEMBL2905814 0.70 CYP2D6 (0.52) SLC6A9CYP2D6CYP19A1GPX4CHRM2
SCHEMBL2914551 0.70 CYP3A4 (0.40) SLC6A9CYP2D6CYP19A1GPX4CHRM2
SCHEMBL1500596 0.70 CYP2D6 (0.52) SLC6A9CYP2D6CYP19A1GPX4CHRM2
SCHEMBL14034023 0.69 CYP2D6 (0.51) SLC6A9CYP2D6CYP19A1GPX4CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355631-B1 TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA AVENTIS PHARMA S.A. (FR) 2002-03-12 US disclosed